Bioleap, Inc
Get Full AccessDescription
- BioLeap is a drug design company that leverages its proprietary technology platform to identify and optimize lead compounds where other approaches have not been successful. Unlike random screening approaches, BioLeaps hypothesis-driven method is particularly effective for designing and improving lead compounds for difficult targets where traditional methods have failed. BioLeaps methodology conceptualizes molecules of practically infinite structural diversity and accurately predicts their relative binding affinity to a target protein. As a result, dramatically fewer compounds need to be synthesized and tested experimentally before achieving pre-clinical milestones. BioLeap creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents, and generates fast-follower compounds for early market entry.
-
Headquarters:346a Lurgan Road , New Hope, Pennsylvania, United States
More -
Phone Number:
-
-
Employees:2
-
Revenue:$0 - 1M
-
Legal Name:Bioleap, Inc
-
Bioleap, Inc's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Bioleap, Inc
-
Where are Bioleap, Inc's Headquarters?
Bioleap, Inc's Headquarters are in 346a Lurgan Road ,New Hope,Pennsylvania,United States
-
What is Bioleap, Inc's Revenue?
Bioleap, Inc's revenue is $0 - 1M
-
What is Bioleap, Inc's NAICS code?
Bioleap, Inc's NAICS code is 325412
-
How many employees are working in Bioleap, Inc
Bioleap, Inc has 2 employees
-
What is Bioleap, Inc's Industry?
Bioleap, Inc is in the industry of Pharmaceuticals
-
Who is Bioleap, Inc's Vice President Licensing?
Bioleap, Inc's Vice President Licensing is Clive Vet
-
Who is Bioleap, Inc's Vice President Chemistry?
Bioleap, Inc's Vice President Chemistry is Ian Cloudsdale

